DNIB UNWIND INC Inactive Instrument
Company DNIB Unwind Inc OTC Bulletin Board
Equities
BINDQ
US05548N1072
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 31/10/06 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
| Corporate Officer/Principal | - | 23/07/16 | |
James L. Wright
PRN | Corporate Officer/Principal | 76 | 31/12/06 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 23/07/16 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 20,886,802 | 17,860,424 ( 85.51 %) | 0 | 85.51 % |
Company contact information
DNIB Unwind, Inc.
333 South Grand Avenue Suite 4100
90071, Los Angeles
+617-491-3400
http://bindtherapeutics.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +7.56% | 111B | |
| +11.37% | 106B | |
| -12.39% | 22.24B | |
| +0.44% | 21.25B | |
| -4.18% | 18.97B | |
| -37.85% | 18.52B | |
| -8.79% | 16.81B | |
| +38.14% | 12.54B | |
| -24.38% | 8.09B |
- Stock Market
- Equities
- BINDQ Stock
- BINDQ Stock
- Company DNIB Unwind Inc
